Novo Holdings A/S Long-Term Concentrated

CIK: 0001388325 · Show all filings

Period: Q2 2018 (← Previous) (Next →)

Filing Date: Feb 6, 2019

Total Value ($000): $994,573

Holdings (19)

INGN INOGEN INC 66.5%
Value ($000) $661,345 Shares 3,549,320 Est. Cost $17.78 Unrealized +836.0%
ACCELERON PHARMA INC 5.4%
Value ($000) $53,563 Shares 1,103,937 Est. Cost $27.65 Unrealized
CRVS CORVUS PHARMACEUTICALS INC 4.9%
Value ($000) $48,537 Shares 4,420,516 Est. Cost $13.03 Unrealized -14.4%
MERUS N V 3.2%
Value ($000) $32,101 Shares 1,410,417 Est. Cost $7.99 Unrealized
AKBA AKEBIA THERAPEUTICS INC 3.1%
Value ($000) $30,938 Shares 3,100,000 Est. Cost $12.34 Unrealized -18.9%
GKOS GLAUKOS CORP 2.5%
Value ($000) $24,494 Shares 602,709 Est. Cost $30.48 Unrealized +16.7%
DERMIRA INC 1.8%
Value ($000) $18,342 Shares 1,993,746 Est. Cost $30.14 Unrealized
KIDS ORTHOPEDIATRICS CORP 1.7%
Value ($000) $17,405 Shares 653,349 Est. Cost $18.69 Unrealized +14.2%
FOLD AMICUS THERAPEUTICS INC 1.7%
Value ($000) $16,888 Shares 1,081,181 Est. Cost $15.12 Unrealized 0.0%
RA PHARMACEUTICALS INC 1.5%
Value ($000) $14,585 Shares 1,465,838 Est. Cost $15.19 Unrealized
SEASPINE HLDGS CORP 1.2%
Value ($000) $11,709 Shares 927,788 Est. Cost $10.14 Unrealized
MENLO THERAPEUTICS INC 1.2%
Value ($000) $11,663 Shares 1,436,313 Est. Cost $36.04 Unrealized
VERONA PHARMA PLC 1.0%
Value ($000) $10,119 Shares 740,740 Est. Cost $11.66 Unrealized
NABRIVA THERAPEUTICS PLC 1.0%
Value ($000) $10,053 Shares 2,888,720 Est. Cost $10.02 Unrealized
UNUM THERAPEUTICS INC 1.0%
Value ($000) $9,545 Shares 665,181 Est. Cost $47.61 Unrealized
AERIE PHARMACEUTICALS INC 0.9%
Value ($000) $8,538 Shares 126,397 Est. Cost $67.55 Unrealized
WRIGHT MED GROUP N V 0.6%
Value ($000) $5,916 Shares 4,622,032 Est. Cost $1.25 Unrealized
INVUITY INC 0.5%
Value ($000) $5,319 Shares 1,363,848 Est. Cost $9.51 Unrealized
C CITIGROUP INC 0.4%
Value ($000) $3,513 Shares 52,500 Est. Cost $53.03 Unrealized 0.0%